Table 3.
Arterial phase characteristics.
| Characteristics of Arterial Phase | HCC (n = 52) |
Non-HCC Malignancy | Benign Lesions | |||||
|---|---|---|---|---|---|---|---|---|
| Metastasis (n = 24) |
ICC (n = 10) |
Lymphoma (n = 2) |
Hemangioma (n = 7) |
FNH (n = 5) |
DN (n = 1) |
AML (n = 1) |
||
| Intensity | ||||||||
| Hyperenhancement | 48 | 13 | 2 | 0 | 3 | 5 | 0 | 1 |
| Isoenhancement | 4 | 9 | 4 | 2 | 0 | 0 | 1 | 0 |
| Hypoenhancement | 0 | 2 | 4 | 0 | 4 | 0 | 0 | 0 |
| Pattern | ||||||||
| Diffuse | 52 | 20 | 7 | 2 | 2 | 5 | 1 | 1 |
| Rim | 0 | 4 | 3 | 0 | 0 | 0 | 0 | 0 |
| Peripheral nodular | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 |
Note: Data are numbers of findings. HCC = hepatocellular carcinoma, ICC = intrahepatic cholangiocarcinoma, FNH = focal nodular hyperplasia, DN = dysplastic nodule, and AML = angiomyolipoma.